Baxter International Inc $ 87.99 0.14 (0.16%)
|Earnings Power Value|
|Net Current Asset Value|| |
|Median P/S Value|
|Peter Lynch Value|
BAX News and Headlines - Baxter International
According to the GuruFocus All-in-One Screener as of Oct. 9, while most of the following companies are trading at a discount, all have positive three- to five-year future earnings estimates.
Shares of CSX Corp. (CSX) were trading around $66 per share on Wednesday.
The American railroad operator has a GuruFocus profitability and growth rating of 8 out of 10. Its earnings per share have risen 22.20% over the last five years. Analysts project a three-year to five-year earnings growth rate of 9.68%. The return on equity of 26.46% and return on assets
Investors may want to put on their radar screen the 15 private and independent biotech companies recognized by FierceBiotech for their novel methods to conquer a variety of diseases.
The companies can be evaluated as potential investments in a number of ways: their technology, therapeutic areas of concentration, the experience and track record of leadership and the size and reputation of their backers.
“Small, gutsy biotechs are still attracting venture capitalists, the public markets and Big Pharma suitors,” Ben Adams wrote in the Sept. 23 article listing the top 15.
Among the young companies, there may be a few
According to current portfolio statistics, Daniel Loeb (Trades, Portfolio)’s top-five holdings as of the second quarter were Baxter International Inc. (BAX), United Technologies Inc. (UTX), Campbell Soup Co. (CPB), Danaher Corp. (DHR) and PayPal Holdings Inc. (PYPL).
Loeb, who founded New York-based Third Point in 1995, leads the firm’s research activities, portfolio and risk management. The firm focuses on a value-oriented, activist investing approach: Loeb seeks investments where a catalyst has potential to increase shareholder value.
The fund manager said in his shareholder letter that the firm returned 13.1% through the first
The guru closed his Anadarko Petroleum Corp. (APC) position when it was acquired by Occidental Petroleum (OXY). The portfolio was impacted by -1.69%.
On its last trading day, the oil and gas producer had a market cap of $36.56 billion and an enterprise value of $55.51 billion.
The DXC Technology Co. (DXC) holding was closed. The portfolio was impacted by -1.47%.
The company, which provides IT
According to the GuruFocus All-in-One Screener, the following companies, as of Thursday, look cheap since they are trading with low price-sales ratios.
Shares of Baxter International Inc. (BAX) are trading around $86 with a price-sales ratio of 4.17 and a price-earnings ratio of 28.91.
The medical products manufacturer has a market cap of $42.87 billion. The stock has risen at an annualized rate of 12.40% over the last 10 years.
The discounted cash flow calculator gives the stock a fair value of $31.89, suggesting it is overpriced by 170%. The Peter Lynch earnings
Daniel Loeb (Trades, Portfolio), founder of hedge fund Third Point, disclosed this week that his top buys for the first quarter included several companies the firm sold out of during the prior quarter, including United Technologies Inc. (UTX) and Marathon Petroleum Corp. (MPC).
Loeb said in his shareholder letter that the Third Point Offshore Fund gained 8.8% during the quarter, driven by strong activist and constructivist positions including Nestle SA (XSWX:NESN), Baxter International Inc. (BAX), United Technologies and Campbell Soup Co. (CPB).
Guru reasserts activist approach to investing
Loeb said in
Daniel Loeb (Trades, Portfolio) of Third Point focuses on activist investing. The firm employs an event-driven, value investment style. The Offshore Fund just published its first-quarter report. It gained 8.8%, driven primarily by activist positions Nestlé (XSWX:NESN), Baxter International (BAX), United Technologies (UTX) and Campbell Soup (CPB).
Third Point also had hedges and shorts in place that held back its performance. This letter was extremely interesting because Loeb talked about some research the firm is doing into long-term executive compensation with some
According to the GuruFocus All-in-One Screener, the following companies are trading at a discount and have positive three- to five-year future earnings estimates.
Shares of China Telecom Corp. Ltd. (CHA) are trading around $52 per share. The discounted cash flow calculator gives the stock a fair value of $102.97 per share, suggesting it is undervalued with a 49% margin of safety.
The Chinese fixed-line operator has a GuruFocus profitability and growth rating of 6 out of 10. Its earnings per share have grown 0.10% over the last five years. Analysts project a three-year
Four New Directors to Be Immediately Appointed to the Board of Directors
Commitment to Adjusted Operating Margin Targets for Q4 2019 and Q4 2020 of 20% and 22.5%, Respectively1
Creation of Finance and Strategy Committee of the Board to Oversee Operational Improvement Initiatives
Increases Share Repurchase Authorization Resulting in $1.5 Billion Available for Repurchase
KANSAS CITY, Mo., April 09, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation ( CERN) (“Cerner” or the “Company”) today announced that the Company has entered into a cooperation
The MS Global Franchise Fund (Trades, Portfolio), part of Morgan Stanley (MS), disclosed this week its top five buys for fourth-quarter 2018 were Baxter International Inc. (BAX), Heineken NV (XAMS:HEIA), Reckitt Benckiser Group PLC (LSE:RB), SAP SE (XTER:SAP) and Microsoft Corp. (MSFT).
The fund seeks long-term capital appreciation through investments in securities with resilient business franchises and growth potential. Key characteristics include sustainable return on invested capital, high gross margins, strong free cash flow generation and good financial strength. As of quarter-end, the 31-stock equity portfolio’s top sectors in terms of weight are consumer
Expanding his position in the health care space, billionaire investor Steven Cohen (Trades, Portfolio), who leads Point72 Asset Management, disclosed a 7.3% stake in Aptevo Therapeutics Inc. (APVO) on March 11.
In order to generate superior risk-adjusted returns, the guru’s Connecticut-based hedge fund uses long, short, macro and systematic strategies.
According to a Schedule 13G filing with the Securities and Exchange Commission, Cohen invested in 3.2 million shares of the Seattle-based biotechnology company.
The company, which develops novel oncology, autoimmune and hematology therapeutics, has a $20.14 million market cap; its shares were trading around 88 cents
Companies that are growing their earnings are often good investments because they can return a solid profit to investors. According to the discounted cash flow calculator, the following undervalued companies have grown their earnings per share over a five-year period.
The earnings per share of Anika Therapeutics Inc. (ANIK) have grown 10% annually over the last five years.
According to the DCF calculator, the stock is undervalued and is trading with a 16% margin of safety at $30 per share. The price-earnings ratio is 23.95. The share price has been as high as $54.88 and
NEW YORK, March 06, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of XPO Logistics, Inc. (:XPO), L3 Technologies Inc. (:LLL), Domino's Pizza Inc (:DPZ), Baxter International Inc. (:BAX), Conduent Inc. (:CNDT), and Xylem Inc. (:XYL), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
The guru’s Connecticut-based firm uses long, short, macro and systematic strategies to generate superior risk-adjusted returns.
According to GuruFocus real-time picks, a Premium feature, Cohen boosted his stake in the Newton, Massachusetts-based company by 127.39%, buying 1.96 million shares for an average price of $5.07 per share. He now holds 3.5 million shares. GuruFocus data shows he has lost approximately 28% on the investment since establishing it in the
Baxter (NYSE:BAX) remains the firm’s largest position and Third Point Partner and Head of Equities Munib Islam serves on the Board of Directors. In past quarterly letters, we detailed our initial investment thesis and highlighted the extraordinary transformation that CEO Joe Almeida has overseen at the company since joining at the end of 2015. Baxter has generated more profits than any investment in our history. We have used open windows to maintain the size of the position as it has grown through appreciation, the best reason to have to right-size an investment. Today, we remain enthusiastic about the direction
Review and Outlook
Third Point’s Offshore Fund lost -11.9% during the Fourth Quarter, bringing returns for 2018 to -11.3%. This was the fourth time in 24 years that we sustained a loss of over 1% in a calendar year and our second double digit decline. Although our performance was disappointing, we took the opportunity to learn from our mistakes, reflect on where our competitive advantages lie, adjust our risk management, and generally improve our processes to drive better results.
Excessive exposure to unhedged long cyclical names and a risk arbitrage position in NXPI accounted for much of the year’s negative
Larry Robbins (Trades, Portfolio), founder of Glenview Capital Management, disclosed last week that he increased his bet in new Daniel Loeb (Trades, Portfolio) holding Cigna Corp. (CI) and established three new holdings during fourth-quarter 2018: Baxter Corp. (BAX), Humana Inc. (HUM) and Livent Corp. (LTHM).
Managing a portfolio of 50 stocks, Robbins focuses on delivering attractive returns through an intense focus on fundamental research and individual security selection. According to current portfolio statistics, Robbins’ long equity portfolio contains 53.12% weight in the health care sector.
The guru closed his United Technologies Corp. (UTX) holding. The trade had an impact of -8.21% on the portfolio.
The company, which provides high technology products and services to the aerospace industries, has a market cap of $105.56 billion and an enterprise value of $147.3 billion.
GuruFocus gives the company a profitability and growth rating of 7 out of 10. The return on equity of 16.26% and return on assets of
NEW YORK, Feb. 04, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ensco plc (:ESV), Third Point Reinsurance Ltd. (:TPRE), Baxter International Inc. (:BAX), Ultrapar Participacoes S.A. (:UGP), Endeavour Silver Corporation (:EXK), and Ingles Markets, Incorporated (IMKTA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links